NEW YORK, Aug. 6 , 2015 /PRNewswire/ -- The fairness of the
proposed acquisition of IPC Healthcare Inc. ("IPCM" or the
"Company") by Team Health Holdings, Inc. ("Team Health") is the
subject of an investigation by WeissLaw LLP, a national class
action, shareholder rights law firm. The investigation
focuses on possible breaches of fiduciary duty and other violations
of law by the Board of Directors of IPCM for agreeing to sell the
Company to Team Health. On August 4,
2015, the Company announced it had reached a definitive
agreement for Team Health to acquire IPCM in a transaction valued
at approximately $1.6 billion.
Under the terms of the agreement, IPCM shareholders will
receive $80.25 for each IPCM share
they own.
WeissLaw is investigating whether IPCM's Board acted to maximize
shareholder. Notably, the Company recently announced positive
financial results, reporting net revenues of $184 million in the second quarter of 2015 as
compared with $172.2 million in the
same period of the previous year, representing a 7% increase
year-over-year. Additionally, IPCM, a national physician group
which manages the care of patients in hospitals and other
medically-related facilities, also reported that patient encounters
grew 14% to nearly 2 million encounters.
Given these facts, WeissLaw is investigating whether IPCM's
Board acted in the best interests of IPCM's public shareholders by
actively shopping the Company to maximize shareholder value.
If you own IPCM shares and would like more information about your
rights or our investigation, or if you have information to share
with us, please contact Joshua Rubin
by telephone at (888) 593-4771 or by email at
stockinfo@weisslawllp.com.
WeissLaw LLP has litigated hundreds of stockholder class and
derivative actions for violations of corporate and fiduciary
duties. We have recovered over a billion dollars for
defrauded clients and obtained important corporate governance
relief in many of these cases. If you have information or
would like legal advice concerning possible corporate wrongdoing
(including insider trading, waste of corporate assets, accounting
fraud, or materially misleading information), consumer fraud
(including false advertising, defective products, or other
deceptive business practices), or anti-trust violations, please
email us at stockinfo@weisslawllp.com or fill out the form
on our website,
http://www.weisslawllp.com/contact/report_fraud/.
Attorney Advertising. Past results do not guarantee a
similar outcome.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/weisslaw-llp-ipc-healthcare-inc-acquisition-may-not-be-in-the-best-interest-of-ipcm-shareholders-300125064.html
SOURCE WeissLaw LLP